Standard
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. / 23andMe Research Team; Wightman, Douglas P; Jansen, Iris E et al.
In:
Nature Genetics, Vol. 53, No. 9, 09.2021, p. 1276-1282.
Research output: Contribution to journal › Article › peer-review
Harvard
23andMe Research Team, Wightman, DP, Jansen, IE, Savage, JE, Shadrin, AA, Bahrami, S, Holland, D, Rongve, A, Børte, S, Winsvold, BS, Drange, OK, Martinsen, AE, Skogholt, AH, Willer, C, Bråthen, G, Bosnes, I, Nielsen, JB, Fritsche, LG, Thomas, LF, Pedersen, LM, Gabrielsen, ME, Johnsen, MB, Meisingset, TW, Zhou, W
, Proitsi, P, Hodges, A, Dobson, R, Velayudhan, L, Sealock, JM, Davis, LK, Pedersen, NL, Reynolds, CA, Karlsson, IK, Magnusson, S, Stefansson, H, Thordardottir, S, Jonsson, PV, Snaedal, J, Zettergren, A, Skoog, I, Kern, S, Waern, M, Zetterberg, H, Blennow, K, Stordal, E, Hveem, K, Zwart, J-A, Athanasiu, L, Selnes, P, Saltvedt, I
& Aarsland, D 2021, '
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease',
Nature Genetics, vol. 53, no. 9, pp. 1276-1282.
https://doi.org/10.1038/s41588-021-00921-zAPA
23andMe Research Team, Wightman, D. P., Jansen, I. E., Savage, J. E., Shadrin, A. A., Bahrami, S., Holland, D., Rongve, A., Børte, S., Winsvold, B. S., Drange, O. K., Martinsen, A. E., Skogholt, A. H., Willer, C., Bråthen, G., Bosnes, I., Nielsen, J. B., Fritsche, L. G., Thomas, L. F.
, ... Aarsland, D. (2021).
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Nature Genetics,
53(9), 1276-1282.
https://doi.org/10.1038/s41588-021-00921-zVancouver
23andMe Research Team, Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S et al.
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Nature Genetics. 2021 Sep;53(9):1276-1282.
https://doi.org/10.1038/s41588-021-00921-zAuthor
23andMe Research Team ; Wightman, Douglas P ; Jansen, Iris E et al. / A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. In: Nature Genetics. 2021 ; Vol. 53, No. 9. pp. 1276-1282.
@article{b6811684cb2d4a02983ef39b1c023712,
title = "A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease",
abstract = "Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.",
author = "{23andMe Research Team} and Wightman, {Douglas P} and Jansen, {Iris E} and Savage, {Jeanne E} and Shadrin, {Alexey A} and Shahram Bahrami and Dominic Holland and Arvid Rongve and Sigrid B{\o}rte and Winsvold, {Bendik S} and Drange, {Ole Kristian} and Martinsen, {Amy E} and Skogholt, {Anne Heidi} and Cristen Willer and Geir Br{\aa}then and Ingunn Bosnes and Nielsen, {Jonas Bille} and Fritsche, {Lars G} and Thomas, {Laurent F} and Pedersen, {Linda M} and Gabrielsen, {Maiken E} and Johnsen, {Marianne Bakke} and Meisingset, {Tore Wergeland} and Wei Zhou and Petroula Proitsi and Angela Hodges and Richard Dobson and Latha Velayudhan and Sealock, {Julia M} and Davis, {Lea K} and Pedersen, {Nancy L} and Reynolds, {Chandra A} and Karlsson, {Ida K} and Sigurdur Magnusson and Hreinn Stefansson and Steinunn Thordardottir and Jonsson, {Palmi V} and Jon Snaedal and Anna Zettergren and Ingmar Skoog and Silke Kern and Margda Waern and Henrik Zetterberg and Kaj Blennow and Eystein Stordal and Kristian Hveem and John-Anker Zwart and Lavinia Athanasiu and Per Selnes and Ingvild Saltvedt and Dag Aarsland",
note = "Funding Information: We thank all the participants included in this study, including the participants from Finngen, GR@CE, IGAP, UKB, DemGene, TwinGene, STSA, the Gothenburg H70 Birth Cohort Studies and Clinical AD from Sweden, ANMerge, BioVU, 23andMe, HUNT, and deCODE. We thank the research participants from 23andMe who made this study possible. We thank the participants of the Norwegian Dementia Genetics Network (DemGene). This work was supported by BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (grant no. 024.004.012). This work was supported by the Research Council of Norway (RCN: 248980, 248778, 223273), Norwegian Regional Health Authorities, Norwegian Health Association (22731, EU JPND: PMI-AD RCN 311993); and National Institutes of Health, National Institute on Aging R01 AG08724, R01 AG17561, R01 AG028555 and R01 AG060470. We thank the International Genomics of Alzheimer{\textquoteright}s Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients and their families. The iSelect chips were funded by the French National Foundation on Alzheimer{\textquoteright}s disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Universit{\'e} de Lille 2 and the Lille University Hospital. GERAD/PERADES was supported by the Medical Research Council (grant no. 503480), Alzheimer{\textquoteright}s Research UK (grant no. 503176), the Wellcome Trust (grant no. 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) (grant nos. 01GI0102, 01GI0711, 01GI0420). CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01–AG–12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants U01 AG032984, U24 AG021886, U01 AG016976 and the Alzheimer{\textquoteright}s Association grant ADGC–10–196728. Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature America, Inc. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = sep,
doi = "10.1038/s41588-021-00921-z",
language = "English",
volume = "53",
pages = "1276--1282",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. SN -",
number = "9",
}
RIS (suitable for import to EndNote) Download
TY - JOUR
T1 - A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
AU - 23andMe Research Team
AU - Wightman, Douglas P
AU - Jansen, Iris E
AU - Savage, Jeanne E
AU - Shadrin, Alexey A
AU - Bahrami, Shahram
AU - Holland, Dominic
AU - Rongve, Arvid
AU - Børte, Sigrid
AU - Winsvold, Bendik S
AU - Drange, Ole Kristian
AU - Martinsen, Amy E
AU - Skogholt, Anne Heidi
AU - Willer, Cristen
AU - Bråthen, Geir
AU - Bosnes, Ingunn
AU - Nielsen, Jonas Bille
AU - Fritsche, Lars G
AU - Thomas, Laurent F
AU - Pedersen, Linda M
AU - Gabrielsen, Maiken E
AU - Johnsen, Marianne Bakke
AU - Meisingset, Tore Wergeland
AU - Zhou, Wei
AU - Proitsi, Petroula
AU - Hodges, Angela
AU - Dobson, Richard
AU - Velayudhan, Latha
AU - Sealock, Julia M
AU - Davis, Lea K
AU - Pedersen, Nancy L
AU - Reynolds, Chandra A
AU - Karlsson, Ida K
AU - Magnusson, Sigurdur
AU - Stefansson, Hreinn
AU - Thordardottir, Steinunn
AU - Jonsson, Palmi V
AU - Snaedal, Jon
AU - Zettergren, Anna
AU - Skoog, Ingmar
AU - Kern, Silke
AU - Waern, Margda
AU - Zetterberg, Henrik
AU - Blennow, Kaj
AU - Stordal, Eystein
AU - Hveem, Kristian
AU - Zwart, John-Anker
AU - Athanasiu, Lavinia
AU - Selnes, Per
AU - Saltvedt, Ingvild
AU - Aarsland, Dag
N1 - Funding Information:
We thank all the participants included in this study, including the participants from Finngen, GR@CE, IGAP, UKB, DemGene, TwinGene, STSA, the Gothenburg H70 Birth Cohort Studies and Clinical AD from Sweden, ANMerge, BioVU, 23andMe, HUNT, and deCODE. We thank the research participants from 23andMe who made this study possible. We thank the participants of the Norwegian Dementia Genetics Network (DemGene). This work was supported by BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (grant no. 024.004.012). This work was supported by the Research Council of Norway (RCN: 248980, 248778, 223273), Norwegian Regional Health Authorities, Norwegian Health Association (22731, EU JPND: PMI-AD RCN 311993); and National Institutes of Health, National Institute on Aging R01 AG08724, R01 AG17561, R01 AG028555 and R01 AG060470. We thank the International Genomics of Alzheimer’s Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients and their families. The iSelect chips were funded by the French National Foundation on Alzheimer’s disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Université de Lille 2 and the Lille University Hospital. GERAD/PERADES was supported by the Medical Research Council (grant no. 503480), Alzheimer’s Research UK (grant no. 503176), the Wellcome Trust (grant no. 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) (grant nos. 01GI0102, 01GI0711, 01GI0420). CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01–AG–12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants U01 AG032984, U24 AG021886, U01 AG016976 and the Alzheimer’s Association grant ADGC–10–196728.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/9
Y1 - 2021/9
N2 - Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.
AB - Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.
UR - http://www.scopus.com/inward/record.url?scp=85114746630&partnerID=8YFLogxK
U2 - 10.1038/s41588-021-00921-z
DO - 10.1038/s41588-021-00921-z
M3 - Article
C2 - 34493870
VL - 53
SP - 1276
EP - 1282
JO - Nature Genetics
JF - Nature Genetics
SN - 1061-4036
IS - 9
ER -